The shares of this pharmaceutical company gained up to 2 percent after the company’s net profit increased by 83.2 percent in the second quarter.
Aurobindo Pharma Ltd is a Large-cap company with a market capitalization of Rs 56,625.11 crores. On Friday, The company shares were trading at Rs 966.40 a share, an increase of 1.66 percent from the previous close price of Rs 950.65 a share.
Looking into the company’s Financials, Aurobindo Pharma Ltd’s revenue increased by 6 percent on a quarter-on-quarter basis from Rs. 6,966.8 crores in Q1FY24 to Rs.7,406.4 crores in Q2 FY24. Further, revenue decreased by 28 percent on a year-on-year basis from Rs. 5,796.5 crores Q2 FY23 to Rs.7,406.4 crores Q2 FY24.
Aurobindo Pharma Ltd’s net profit increased by 32 percent on a quarter-on-quarter basis from Rs. 569.7 crores in Q1 FY24 to Rs. 751.9 crores in Q2 FY24. Further, net profit increased by 83 percent on a year-on-year basis from Rs. 410.3 crores Q2 FY23 to Rs.751.9 crores Q2 FY24.
Aurobindo Pharma Ltd’s reported return ratios in the recent financial year with a return on equity (ROE) of 7.5 percent and a return on capital employed (ROCE) of 9.39 percent.
Aurobindo Pharma Ltd’s stock gave a multi-bagger return of 105.5 percent a year. A shareholder investment of Rs 1 lakh in the company would be worth Rs 2.05 Lakh in a year.
Aurobindo Pharma Ltd’s recent shareholding pattern, The Promoters of the Company own 51.83 percent while Retail shareholders own a 7.42 percent stake in the company and Foreign Institutional Investors own a 22.4 percent stake.
Aurobindo Pharma is engaged with the production and distribution of generic medications, active pharmaceutical ingredients, and associated services.
Written By:- Abhishek Singh
